Valve-Controlled Reduced Pressure Dressing for Multi-Site Wound Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing reduced pressure tissue treatment systems face challenges in preventing cross-contamination between multiple tissue sites when treated simultaneously, as fluids can flow between sites, potentially spreading infectious materials and complicating healing.

Innovation Solution

Incorporating a valve system that controls fluid flow to and from each tissue site, preventing backflow and cross-contamination by using various valve configurations that open or close based on pressure differentials, ensuring directional flow control and maintaining reduced pressure levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If multiple tissue sites are treated simultaneously using a single reduced pressure source, then treatment efficiency is improved, but cross-contamination between sites occurs due to uncontrolled fluid flow

Engineering Contradiction:
Improvetreatment efficiencyVSAvoidcross-contamination
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The system divides the fluid flow path into separate segments for each tissue site by incorporating individual valves at each site. This segmentation allows simultaneous treatment of multiple sites while preventing cross-contamination through controlled isolation of each site's fluid pathway.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Valves are introduced as intermediary components between the reduced pressure source and each tissue site. These valves act as mediators that control fluid flow direction and prevent backflow, thereby eliminating cross-contamination while maintaining efficient simultaneous treatment of multiple sites.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If valves are added to control fluid flow at each tissue site, then cross-contamination is prevented, but device complexity increases

Engineering Contradiction:
Improvecross-contamination preventionVSAvoidsystem complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The valves are designed to automatically respond to pressure differentials without requiring external control mechanisms. Each valve self-regulates fluid flow based on local pressure conditions, preventing cross-contamination while minimizing the need for additional complex control systems.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system uses pressure differential-based valve operation where the pneumatic/hydraulic pressure from the reduced pressure source automatically controls valve opening and closing. This eliminates the need for mechanical actuators, motors, or electronic controls, thereby preventing cross-contamination without significantly increasing device complexity.

Inventive Principle:
Principle #29Pneumatics and hydraulics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The valve system effectively prevents cross-contamination and backflow, ensuring each tissue site receives controlled reduced pressure, thereby enhancing treatment efficacy and reducing healing complications for multiple tissue sites.

Implementation Method 1

various valve configurations that open or close based on pressure differentials

Methodology Applied
Scientific EffectPressure differential: Pressure Gradient

Data Source

PatentUS9981075B2Reduced pressure tissue treatment systems and methods having a reduced pressure dressing and associated valve
Publication Date: 2018.05.29 KCI LICENSING INC
  • US9981075B2 patent drawing
  • US9981075B2 patent drawing
  • US9981075B2 patent drawing

AI summary

A system for treating multiple tissue sites of a patient includes a first dressing filler adapted to be positioned at a first of the tissue sites. A second dressing filler is adapted to be positioned at a second of the tissue sites. A bridge manifold is positioned between the first tissue site and the second tissue site to provide fluid communication between the first and the second tissue site. A reduced pressure source is fluidly connected to at least one of the bridge manifold, the first tissue site, and the second tissue site. A valve is operably associated with one of the first and the second tissue sites to allow fluid to flow from the one of the first and the second tissue sites, but precluding flow towards the one of the first and the second tissue sites.